GSK Pharmaceuticals heads into a period of consolidation – Livemint.com

Growth would have been higher, but for slower demand for anti-infective products during the year. The vaccines business did well, with sales rising 58% in 2011. Speciality business reported 25% growth, dermatology rose by 14% and mass products by 7-8% …